Correlation Between Inozyme Pharma and Arcutis Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Arcutis Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Arcutis Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Arcutis Biotherapeutics, you can compare the effects of market volatilities on Inozyme Pharma and Arcutis Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Arcutis Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Arcutis Biotherapeutics.
Diversification Opportunities for Inozyme Pharma and Arcutis Biotherapeutics
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Inozyme and Arcutis is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Arcutis Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcutis Biotherapeutics and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Arcutis Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcutis Biotherapeutics has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Arcutis Biotherapeutics go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Arcutis Biotherapeutics
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Arcutis Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.03 times less risky than Arcutis Biotherapeutics. The stock trades about -0.42 of its potential returns per unit of risk. The Arcutis Biotherapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 936.00 in Arcutis Biotherapeutics on August 28, 2024 and sell it today you would earn a total of 141.00 from holding Arcutis Biotherapeutics or generate 15.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Arcutis Biotherapeutics
Performance |
| Timeline |
| Inozyme Pharma |
| Arcutis Biotherapeutics |
Inozyme Pharma and Arcutis Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Arcutis Biotherapeutics
The main advantage of trading using opposite Inozyme Pharma and Arcutis Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Arcutis Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcutis Biotherapeutics will offset losses from the drop in Arcutis Biotherapeutics' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Arcutis Biotherapeutics vs. Terns Pharmaceuticals | Arcutis Biotherapeutics vs. Amylyx Pharmaceuticals | Arcutis Biotherapeutics vs. Acumen Pharmaceuticals | Arcutis Biotherapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |